Table 2:
Clinicopathological characteristics of all patients
| Characteristic | Patients with LELC (n = 39) |
|---|---|
| Sex | |
| Male | 15 (38.5%) |
| Female | 24 (61.5%) |
| Age (years) | |
| Median | 47 |
| Range | 36–81 |
| Main complaint | |
| Cough | 14 (35.9%) |
| Haemoptysis | 6 (15.4%) |
| Chest pain | 3 (7.7%) |
| Asymptomatic | 16 (41.0%) |
| Smoking history | |
| Former or current smoker | 7 (17.9%) |
| Non-smoker | 32 (82.1%) |
| Locations | |
| Right upper lobe | 5 (12.8%) |
| Right middle lobe | 12 (30.8%) |
| Right lower lobe | 3 (7.7%) |
| Right middle and lower lobes | 1 (2.6%) |
| Left upper lobe | 7 (17.9%) |
| Left lower lobe | 11 (28.2%) |
| Tumour diameter (cm) | 4.27±0.29 |
| Operation | |
| Lung wedge resection | 1 (2.6%) |
| Lobectomy | 33 (84.6%) |
| Bilobectomy | 3 (7.7%) |
| Pneumonectomy | 2 (5.1%) |
| T stage | |
| T1 | 9 (23.1%) |
| T2 | 26 (66.7%) |
| T3 | 4 (10.3%) |
| N stage | |
| N0 | 23 (59.0%) |
| N1 | 7 (17.9%) |
| N2 | 9 (23.1%) |
| TNM stage | |
| I | 18 (46.2%) |
| II | 10 (25.6%) |
| IIIa | 11 (28.2%) |
| Adjuvant therapy | |
| Sole chemotherapy | 24 (61.5%) |
| Sole radiation | 1 (2.6%) |
| Chemoradiation | 1 (2.6%) |
| No adjuvant therapy | 13 (33.3%) |